HK Stock MarketDetailed Quotes

02252 MEDBOT-B

Watchlist
  • 12.900
  • +0.280+2.22%
Not Open Apr 25 16:09 CST
12.37BMarket Cap-11072P/E (TTM)

MEDBOT-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(Q3)Mar 31, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(Q3)Mar 31, 2020
Turnover
384.15%104.59M
4,442.27%47.6M
904.79%21.6M
--1.05M
--2.15M
----
----
----
----
----
Operating income
384.15%104.59M
4,442.27%47.6M
904.79%21.6M
1.05M
2.15M
Cost of sales
-497.69%-89.9M
-7,052.66%-25.54M
-1,121.85%-15.04M
---357K
---1.23M
----
----
----
----
----
Operating expenses
-497.69%-89.9M
-7,052.66%-25.54M
-1,121.85%-15.04M
-357K
-1.23M
Gross profit
123.93%14.69M
3,093.63%22.07M
614.04%6.56M
691K
919K
Selling expenses
-29.55%-238.43M
-97.80%-126.91M
-132.41%-184.04M
-337.74%-64.16M
-2,840.51%-79.19M
-1,602.32%-14.66M
-847.92%-4.1M
---2.69M
---861K
---432K
Administrative expenses
25.88%-126.36M
-19.13%-77.6M
-58.61%-170.47M
-24.14%-65.14M
-299.78%-107.48M
-541.45%-52.47M
-374.87%-25.09M
-152.15%-26.88M
---8.18M
---5.28M
Research and development expenses
24.69%-569.18M
7.35%-311.7M
-92.49%-755.8M
-110.16%-336.41M
-190.04%-392.65M
-294.82%-160.07M
-387.61%-90.07M
-118.77%-135.38M
---40.54M
---18.47M
Revaluation surplus
-57.59%-42.53M
-120.12%-1.92M
-159.28%-26.98M
283.31%9.53M
1,500.71%45.52M
---5.2M
---2.14M
---3.25M
----
----
-Changes in the fair value of financial assets
-57.59%-42.53M
-120.12%-1.92M
---26.98M
283.31%9.53M
----
---5.2M
----
---3.25M
----
----
-Changes in the fair value of other assets
----
----
----
----
--45.52M
----
---2.14M
----
----
----
Special items of operating profit
-137.61%-13.34M
-248.11%-23.21M
288.47%35.48M
1,492.89%15.67M
-292.52%-18.82M
19.85%984K
1,350.82%9.74M
198.72%9.78M
--821K
--671K
Operating profit
10.97%-975.14M
-18.06%-519.26M
-98.53%-1.1B
-90.06%-439.82M
-248.23%-551.7M
-374.56%-231.41M
-374.83%-111.66M
-128.71%-158.43M
-48.76M
-23.52M
Financing cost
-63.56%-18.59M
-55.15%-8.62M
-109.13%-11.37M
-688.37%-5.56M
88.95%-5.44M
-247.29%-705K
-162.50%-273K
-9,163.09%-49.19M
---203K
---104K
Special items of earning before tax
24.84%-29.8M
7.04%-16.85M
-44.85%-39.66M
-73.54%-18.12M
-1,534.45%-27.38M
---10.44M
---2.84M
---1.68M
----
----
Earning before tax
10.71%-1.02B
-17.53%-544.73M
-96.11%-1.15B
-91.09%-463.5M
-179.28%-584.51M
-395.36%-242.56M
-385.91%-114.77M
-199.84%-209.29M
-48.97M
-23.62M
After-tax profit from continuing operations
10.71%-1.02B
-17.53%-544.73M
-96.11%-1.15B
-91.09%-463.5M
-179.28%-584.51M
-395.36%-242.56M
-385.91%-114.77M
-199.84%-209.29M
-48.97M
-23.62M
Earning after tax
10.71%-1.02B
-17.53%-544.73M
-96.11%-1.15B
-91.09%-463.5M
-179.28%-584.51M
-395.36%-242.56M
-385.91%-114.77M
-199.84%-209.29M
-48.97M
-23.62M
Minority profit
-75.30%-11.36M
-28.59%-5.72M
-308.45%-6.48M
-647.73%-4.45M
-281.25%-1.59M
---595K
---362K
---416K
----
----
Profit attributable to shareholders
11.20%-1.01B
-17.42%-539.01M
-95.53%-1.14B
-89.72%-459.05M
-179.08%-582.92M
-394.15%-241.97M
-384.37%-114.41M
-199.24%-208.87M
-48.97M
-23.62M
Basic earnings per share
10.92%-1.06
-16.67%-0.56
-88.89%-1.19
-77.78%-0.48
-133.33%-0.63
-285.71%-0.27
-333.33%-0.13
-145.45%-0.27
-0.07
-0.03
Diluted earnings per share
10.92%-1.06
-16.67%-0.56
-88.89%-1.19
-77.78%-0.48
-133.33%-0.63
-285.71%-0.27
-333.33%-0.13
-145.45%-0.27
-0.07
-0.03
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
--
Unqualified Opinion
--
--
Auditor
KPMG
--
KPMG
--
KPMG
--
--
KPMG
--
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(Q3)Mar 31, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(Q3)Mar 31, 2020
Turnover 384.15%104.59M4,442.27%47.6M904.79%21.6M--1.05M--2.15M--------------------
Operating income 384.15%104.59M4,442.27%47.6M904.79%21.6M1.05M2.15M
Cost of sales -497.69%-89.9M-7,052.66%-25.54M-1,121.85%-15.04M---357K---1.23M--------------------
Operating expenses -497.69%-89.9M-7,052.66%-25.54M-1,121.85%-15.04M-357K-1.23M
Gross profit 123.93%14.69M3,093.63%22.07M614.04%6.56M691K919K
Selling expenses -29.55%-238.43M-97.80%-126.91M-132.41%-184.04M-337.74%-64.16M-2,840.51%-79.19M-1,602.32%-14.66M-847.92%-4.1M---2.69M---861K---432K
Administrative expenses 25.88%-126.36M-19.13%-77.6M-58.61%-170.47M-24.14%-65.14M-299.78%-107.48M-541.45%-52.47M-374.87%-25.09M-152.15%-26.88M---8.18M---5.28M
Research and development expenses 24.69%-569.18M7.35%-311.7M-92.49%-755.8M-110.16%-336.41M-190.04%-392.65M-294.82%-160.07M-387.61%-90.07M-118.77%-135.38M---40.54M---18.47M
Revaluation surplus -57.59%-42.53M-120.12%-1.92M-159.28%-26.98M283.31%9.53M1,500.71%45.52M---5.2M---2.14M---3.25M--------
-Changes in the fair value of financial assets -57.59%-42.53M-120.12%-1.92M---26.98M283.31%9.53M-------5.2M-------3.25M--------
-Changes in the fair value of other assets ------------------45.52M-------2.14M------------
Special items of operating profit -137.61%-13.34M-248.11%-23.21M288.47%35.48M1,492.89%15.67M-292.52%-18.82M19.85%984K1,350.82%9.74M198.72%9.78M--821K--671K
Operating profit 10.97%-975.14M-18.06%-519.26M-98.53%-1.1B-90.06%-439.82M-248.23%-551.7M-374.56%-231.41M-374.83%-111.66M-128.71%-158.43M-48.76M-23.52M
Financing cost -63.56%-18.59M-55.15%-8.62M-109.13%-11.37M-688.37%-5.56M88.95%-5.44M-247.29%-705K-162.50%-273K-9,163.09%-49.19M---203K---104K
Special items of earning before tax 24.84%-29.8M7.04%-16.85M-44.85%-39.66M-73.54%-18.12M-1,534.45%-27.38M---10.44M---2.84M---1.68M--------
Earning before tax 10.71%-1.02B-17.53%-544.73M-96.11%-1.15B-91.09%-463.5M-179.28%-584.51M-395.36%-242.56M-385.91%-114.77M-199.84%-209.29M-48.97M-23.62M
After-tax profit from continuing operations 10.71%-1.02B-17.53%-544.73M-96.11%-1.15B-91.09%-463.5M-179.28%-584.51M-395.36%-242.56M-385.91%-114.77M-199.84%-209.29M-48.97M-23.62M
Earning after tax 10.71%-1.02B-17.53%-544.73M-96.11%-1.15B-91.09%-463.5M-179.28%-584.51M-395.36%-242.56M-385.91%-114.77M-199.84%-209.29M-48.97M-23.62M
Minority profit -75.30%-11.36M-28.59%-5.72M-308.45%-6.48M-647.73%-4.45M-281.25%-1.59M---595K---362K---416K--------
Profit attributable to shareholders 11.20%-1.01B-17.42%-539.01M-95.53%-1.14B-89.72%-459.05M-179.08%-582.92M-394.15%-241.97M-384.37%-114.41M-199.24%-208.87M-48.97M-23.62M
Basic earnings per share 10.92%-1.06-16.67%-0.56-88.89%-1.19-77.78%-0.48-133.33%-0.63-285.71%-0.27-333.33%-0.13-145.45%-0.27-0.07-0.03
Diluted earnings per share 10.92%-1.06-16.67%-0.56-88.89%-1.19-77.78%-0.48-133.33%-0.63-285.71%-0.27-333.33%-0.13-145.45%-0.27-0.07-0.03
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion----Unqualified Opinion----
Auditor KPMG--KPMG--KPMG----KPMG----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg